Expert urologists from Columbia and Weill Cornell Medicine offer unparalleled services for patients with both common and complex urologic diseases and disorders, including significant experience and expertise in prostate, bladder, and other urologic cancers. Through clinical trials and basic research, our clinicians contribute to the development of novel diagnostics, new medications, and improved surgical techniques to optimize the lives of their patients.
Urology
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
